Pyros Pharma`s Vigafyde (vigabatrin) Receives Approval in the U.S
Pyros Pharmaceuticals Announces FDA Approval of VIGAFYDE™
Pyros Pharms New Vigabatrin Receives Approval in US
Pyros Pharmaceuticals Announces FDA Approval of VIGAFYDE™ (vigabatrin) as the First and Only Ready-to-Use Vigabatrin Oral Solution
Pyros Pharmaceuticals Announces VIGPODER™ (vigabatrin) is Now Available
Pyros Announces Positive Outcome of the Procedure for Approval of VIGZIP
Pyros Pharmaceuticals’ Abstract Accepted for Poster Presentation at the American Epilepsy Society (AES) 2023 Annual Meeting